metformin has been researched along with pyrogallol in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, Q; Kong, L; Ma, Z; Parris, AB; Shi, Y; Wu, Y; Yang, X | 1 |
1 other study(ies) available for metformin and pyrogallol
Article | Year |
---|---|
FGFR1 overexpression renders breast cancer cells resistant to metformin through activation of IRS1/ERK signaling.
Topics: Breast Neoplasms; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Insulin Receptor Substrate Proteins; MAP Kinase Signaling System; MCF-7 Cells; Metformin; Pyrogallol; Receptor, Fibroblast Growth Factor, Type 1; Receptor, IGF Type 1; Sulfonamides; TOR Serine-Threonine Kinases | 2021 |